<DOC>
	<DOCNO>NCT02718001</DOCNO>
	<brief_summary>Early feasibility study evaluate safety function Edwards Lifesciences CardiAQ™ Transcatheter Mitral Valve</brief_summary>
	<brief_title>Edwards Lifesciences CardiAQ™ Transcatheter Mitral Valve Replacement ( TMVR ) Early Feasibility Study</brief_title>
	<detailed_description>The study multi-center , prospective , single-arm , non-randomized study design evaluate safety function Edwards Lifesciences CardiAQ™ Transcatheter Mitral Valve Transfemoral Transapical Delivery Systems .</detailed_description>
	<mesh_term>Mitral Valve Insufficiency</mesh_term>
	<criteria>Clinically significant , symptomatic mitral regurgitation High risk openheart surgery Meets anatomical criterion Unsuitable anatomy Prohibitively high risk</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>Mitral</keyword>
	<keyword>Regurgitation</keyword>
	<keyword>Insufficiency</keyword>
	<keyword>Degenerative</keyword>
	<keyword>Functional</keyword>
	<keyword>Primary</keyword>
	<keyword>Secondary</keyword>
	<keyword>Organic</keyword>
	<keyword>Transcatheter</keyword>
	<keyword>TMVR</keyword>
	<keyword>TMVI</keyword>
	<keyword>Heart Valve</keyword>
	<keyword>Mitral Valve</keyword>
	<keyword>Transapical</keyword>
	<keyword>Transseptal</keyword>
	<keyword>Trans-Septal</keyword>
	<keyword>Transeptal</keyword>
	<keyword>Severe</keyword>
</DOC>